Meet sterna

BIO-Europe® 2019
Hamburg, GER
November 11 – 13, 2019

Deutsches Eigenkapitalforum 2019
Frankfurt/Main, GER
November 25 – 27, 2019
Presentation Venture Stage on Tuesday, Nov 26, 2 pm

Welcome to sterna biologicals

sterna biologicals is a biopharmaceutical company developing novel treatments for chronic inflammatory diseases such as asthma, COPD, atopic dermatitis, and ulcerative colitis. By adressing GATA-3, a master transcription factor that plays a pivotal role in regulating type-2 inflammation, the company's next generation antisense molecule hgd40, a DNAzyme, provides truly new and highly promising therapeutic options.